SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-143829
Filing Date
2022-05-06
Accepted
2022-05-06 17:25:31
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d252049ds3.htm S-3 395212
2 EX-1.2 d252049dex12.htm EX-1.2 224513
3 EX-5.1 d252049dex51.htm EX-5.1 30688
4 EX-5.2 d252049dex52.htm EX-5.2 4993
5 EX-23.1 d252049dex231.htm EX-23.1 1541
6 EX-FILING FEES d252049dexfilingfees.htm EX-FILING FEES 44157
7 GRAPHIC g252049g04p10.jpg GRAPHIC 55333
8 GRAPHIC g252049g0505110924722.jpg GRAPHIC 6030
9 GRAPHIC g252049g40p17.jpg GRAPHIC 56524
  Complete submission text file 0001193125-22-143829.txt   853045
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264773 | Film No.: 22902489
SIC: 2834 Pharmaceutical Preparations